{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:48:31Z","timestamp":1759402111927,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["HU22C0143000022","2021M3H4A4079521","HI17C1711"],"award-info":[{"award-number":["HU22C0143000022","2021M3H4A4079521","HI17C1711"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05666-x","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T06:01:51Z","timestamp":1728540111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["AIMP2 accumulation in brain leads to cognitive deficits and blood secretion in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Heejeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Yong","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangwoo","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gum Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nae-Eung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0182-2279","authenticated-orcid":false,"given":"Yunjong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"5666_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A. Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna). 2017;124:901\u20135.","journal-title":"J Neural Transm (Vienna)"},{"key":"5666_CR2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang AE, Lozano AM. Parkinson\u2019s disease. First of two parts. N Engl J Med. 1998;339:1044\u201353.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"5666_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W. Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol. 2008;15(Suppl 1):14\u201320.","journal-title":"Eur J Neurol"},{"key":"5666_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA. Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J Neural Transm (Vienna). 2018;125:615\u201350.","journal-title":"J Neural Transm (Vienna)"},{"key":"5666_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.21541","volume":"64","author":"RE Burke","year":"2008","unstructured":"Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol. 2008;64:485\u201391.","journal-title":"Ann Neurol"},{"doi-asserted-by":"crossref","unstructured":"Ham S, Yun SP, Kim H, Kim D, Seo BA, Kim H, Shin JY, Dar MA, Lee GH, Lee YI et al. Amyloid-like oligomerization of AIMP2 contributes to alpha-synuclein interaction and lewy-like inclusion. Sci Transl Med. 2020;12.","key":"5666_CR6","DOI":"10.1126\/scitranslmed.aax0091"},{"key":"5666_CR7","doi-asserted-by":"publisher","first-page":"16691","DOI":"10.1073\/pnas.1006083107","volume":"107","author":"HS Ko","year":"2010","unstructured":"Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin\u2019s ubiquitination and protective function. Proc Natl Acad Sci U S A. 2010;107:16691\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5666_CR8","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nn.3500","volume":"16","author":"Y Lee","year":"2013","unstructured":"Lee Y, Karuppagounder SS, Shin JH, Lee YI, Ko HS, Swing D, Jiang H, Kang SU, Lee BD, Kang HC, et al. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat Neurosci. 2013;16:1392\u2013400.","journal-title":"Nat Neurosci"},{"key":"5666_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D. Advances in markers of prodromal Parkinson disease. Nat Rev Neurol. 2016;12:622\u201334.","journal-title":"Nat Rev Neurol"},{"key":"5666_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1017\/S0317167100031814","volume":"18","author":"AH Rajput","year":"1991","unstructured":"Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism\u2013a prospective study. Can J Neurol Sci. 1991;18:275\u20138.","journal-title":"Can J Neurol Sci"},{"issue":"Pt 5","key":"5666_CR11","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991;114(Pt 5):2283\u2013301.","journal-title":"Brain"},{"key":"5666_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik A, Stewart T, Zhang J. Alpha-Synuclein as a biomarker for Parkinson\u2019s disease. Brain Pathol. 2016;26:410\u20138.","journal-title":"Brain Pathol"},{"key":"5666_CR13","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.molmed.2020.03.012","volume":"26","author":"N Uemura","year":"2020","unstructured":"Uemura N, Uemura MT, Luk KC, Lee VM, Trojanowski JQ. Cell-to-cell transmission of tau and alpha-synuclein. Trends Mol Med. 2020;26:936\u201352.","journal-title":"Trends Mol Med"},{"key":"5666_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","volume":"64","author":"X Lin","year":"2009","unstructured":"Lin X, Parisiadou L, Gu XL, Wang L, Shim H, Sun L, Xie C, Long CX, Yang WJ, Ding J, et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant alpha-synuclein. Neuron. 2009;64:807\u201327.","journal-title":"Neuron"},{"key":"5666_CR15","doi-asserted-by":"publisher","first-page":"17335","DOI":"10.1523\/JNEUROSCI.1917-13.2013","volume":"33","author":"MJ Yetman","year":"2013","unstructured":"Yetman MJ, Jankowsky JL. Wild-type neural progenitors divide and differentiate normally in an amyloid-rich environment. J Neurosci. 2013;33:17335\u201341.","journal-title":"J Neurosci"},{"key":"5666_CR16","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/hmg\/ddg159","volume":"12","author":"O Corti","year":"2003","unstructured":"Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S, Prigent A, Robinson JC, Pradier L, Ruberg M, Mirande M, et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet. 2003;12:1427\u201337.","journal-title":"Hum Mol Genet"},{"key":"5666_CR17","doi-asserted-by":"publisher","first-page":"7968","DOI":"10.1523\/JNEUROSCI.2172-05.2005","volume":"25","author":"HS Ko","year":"2005","unstructured":"Ko HS, von Coelln R, Sriram SR, Kim SW, Chung KK, Pletnikova O, Troncoso J, Johnson B, Saffary R, Goh EL, et al. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38\/JTV-1, leads to catecholaminergic cell death. J Neurosci. 2005;25:7968\u201378.","journal-title":"J Neurosci"},{"key":"5666_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1523\/JNEUROSCI.1833-10.2011","volume":"31","author":"SZ Imam","year":"2011","unstructured":"Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, Bains M, Roberts JL, Kahle PJ, Clark RA, Li S. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson\u2019s disease. J Neurosci. 2011;31:157\u201363.","journal-title":"J Neurosci"},{"key":"5666_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41583-019-0260-z","volume":"21","author":"T Hainmueller","year":"2020","unstructured":"Hainmueller T, Bartos M. Dentate gyrus circuits for encoding, retrieval and discrimination of episodic memories. Nat Rev Neurosci. 2020;21:153\u201368.","journal-title":"Nat Rev Neurosci"},{"key":"5666_CR20","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH. Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci. 2017;37:1675\u201384.","journal-title":"J Neurosci"},{"key":"5666_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1538\/expanim.60.111","volume":"60","author":"XL An","year":"2011","unstructured":"An XL, Zou JX, Wu RY, Yang Y, Tai FD, Zeng SY, Jia R, Zhang X, Liu EQ, Broders H. Strain and sex differences in anxiety-like and social behaviors in C57BL\/6J and BALB\/cJ mice. Exp Anim. 2011;60:111\u201323.","journal-title":"Exp Anim"},{"doi-asserted-by":"crossref","unstructured":"Kim H, Shin JY, Lee YS, Yun SP, Maeng HJ, Lee Y. Brain endothelial p-glycoprotein level is reduced in Parkinson\u2019s disease via a vitamin D receptor-dependent pathway. Int J Mol Sci. 2020;21.","key":"5666_CR22","DOI":"10.3390\/ijms21228538"},{"key":"5666_CR23","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S, Masliah E, Hwang D, Lee HJ, Lee SJ. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013;4:1562.","journal-title":"Nat Commun"},{"doi-asserted-by":"crossref","unstructured":"Mao X, Ou MT, Karuppagounder SS, Kam TI, Yin X, Xiong Y, Ge P, Umanah GE, Brahmachari S, Shin JH et al. Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. 2016;353.","key":"5666_CR24","DOI":"10.1126\/science.aah3374"},{"key":"5666_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","volume":"128","author":"M Shi","year":"2014","unstructured":"Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, et al. Plasma exosomal alpha-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease. Acta Neuropathol. 2014;128:639\u201350.","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05666-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T18:05:00Z","timestamp":1728583500000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05666-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5666"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05666-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"type":"electronic","value":"1479-5876"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee of Sungkyunkwan University and were conducted in accordance with all applicable international guidelines (SKKUIACUC2020-05-04-1). The use of human plasma samples was approved by the appropriate institutional review board (SKKU 2018-07-018-001; HY-2021-06-040)).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.H., and Y.L. are inventors of the patent related to this work (South Korea domestic patent no. 10-2252879, \u201cMethod for diagnosing Parkinson\u2019s disease using AIMP2 in blood plasma, composition therefor and kit containing the same\u201d). The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"919"}}